Cargando…
The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study
AIMS: Intralesional curettage is a commonly used treatment for primary bone tumors. However, local recurrence of tumors after curettage remains a major challenge. QUESTIONS: (1) Is blood pressure related to local recurrence after intralesional curettage for benign or intermediate bone tumors? (2) Wh...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892695/ https://www.ncbi.nlm.nih.gov/pubmed/35241034 http://dx.doi.org/10.1186/s12891-022-05157-4 |
_version_ | 1784662232457543680 |
---|---|
author | Zhou, Lenian Lin, Shanyi Zhu, Hongyi Dong, Yang Yang, Qingcheng Yuan, Ting |
author_facet | Zhou, Lenian Lin, Shanyi Zhu, Hongyi Dong, Yang Yang, Qingcheng Yuan, Ting |
author_sort | Zhou, Lenian |
collection | PubMed |
description | AIMS: Intralesional curettage is a commonly used treatment for primary bone tumors. However, local recurrence of tumors after curettage remains a major challenge. QUESTIONS: (1) Is blood pressure related to local recurrence after intralesional curettage for benign or intermediate bone tumors? (2) What’s the impact of tourniquet usage on the risk of recurrence from high blood pressure? METHODS: This retrospective study evaluated patients receiving intralesional curettage for primary bone tumors from January 2011 to January 2015. A total of 411 patients with a minimum five-year follow-up were included for analysis. Demographic and disease-related variables were first assessed in univariable analyses for local recurrence risk. When a yielded p-value was < 0.2, variables were included in multivariable analyses to identify independent risk factors for local recurrence. Patients were then stratified by tourniquet usage (use/non-use), and risk from high blood pressure was evaluated in both subgroups. RESULTS: At an average follow-up of 6.8 ± 1.0 years, 63 of 411 patients (15.3%) experienced local recurrence. In multivariable analyses, local recurrence was associated with age (OR, 0.96; 95% CI, 0.94–0.99; p = 0.005); tumor type; lesion size (> 5 cm: OR, 3.58; 95% CI, 1.38–9.33; p = 0.009); anatomical site (proximal femur: OR, 2.49; 95% CI, 1.21–5.15; p = 0.014; proximal humerus: OR, 3.34; 95% CI, 1.61–6.92; p = 0.001); and preoperative mean arterial pressure (> 110 mmHg: OR, 2.61; 95% CI, 1.20–5.67; P = 0.015). In subgroup analyses, after adjusting for age, tumor type, lesion size, and anatomical site, tourniquet use modified the preoperative mean arterial pressure - recurrence relationship: when tourniquet was not used, preoperative mean arterial pressure predicted local recurrence (95–110 mmHg, 4.13, 1.42–12.03, p = 0.009; > 110 mmHg, 28.06, 5.27–149.30, p < 0.001); when tourniquet was used, preoperative mean arterial pressure was not related to local recurrence (all p values > 0.05). CONCLUSIONS: A high preoperative blood pressure was related to local recurrence after intralesional curettage for primary bone tumors in our study. Tourniquet usage and controlling blood pressure might be beneficial for reducing local recurrence in patients scheduled to receive intralesional curettage for primary bone tumor treatment. LEVEL OF EVIDENCE: Level IV, hypothesis-generating study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05157-4. |
format | Online Article Text |
id | pubmed-8892695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88926952022-03-10 The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study Zhou, Lenian Lin, Shanyi Zhu, Hongyi Dong, Yang Yang, Qingcheng Yuan, Ting BMC Musculoskelet Disord Research AIMS: Intralesional curettage is a commonly used treatment for primary bone tumors. However, local recurrence of tumors after curettage remains a major challenge. QUESTIONS: (1) Is blood pressure related to local recurrence after intralesional curettage for benign or intermediate bone tumors? (2) What’s the impact of tourniquet usage on the risk of recurrence from high blood pressure? METHODS: This retrospective study evaluated patients receiving intralesional curettage for primary bone tumors from January 2011 to January 2015. A total of 411 patients with a minimum five-year follow-up were included for analysis. Demographic and disease-related variables were first assessed in univariable analyses for local recurrence risk. When a yielded p-value was < 0.2, variables were included in multivariable analyses to identify independent risk factors for local recurrence. Patients were then stratified by tourniquet usage (use/non-use), and risk from high blood pressure was evaluated in both subgroups. RESULTS: At an average follow-up of 6.8 ± 1.0 years, 63 of 411 patients (15.3%) experienced local recurrence. In multivariable analyses, local recurrence was associated with age (OR, 0.96; 95% CI, 0.94–0.99; p = 0.005); tumor type; lesion size (> 5 cm: OR, 3.58; 95% CI, 1.38–9.33; p = 0.009); anatomical site (proximal femur: OR, 2.49; 95% CI, 1.21–5.15; p = 0.014; proximal humerus: OR, 3.34; 95% CI, 1.61–6.92; p = 0.001); and preoperative mean arterial pressure (> 110 mmHg: OR, 2.61; 95% CI, 1.20–5.67; P = 0.015). In subgroup analyses, after adjusting for age, tumor type, lesion size, and anatomical site, tourniquet use modified the preoperative mean arterial pressure - recurrence relationship: when tourniquet was not used, preoperative mean arterial pressure predicted local recurrence (95–110 mmHg, 4.13, 1.42–12.03, p = 0.009; > 110 mmHg, 28.06, 5.27–149.30, p < 0.001); when tourniquet was used, preoperative mean arterial pressure was not related to local recurrence (all p values > 0.05). CONCLUSIONS: A high preoperative blood pressure was related to local recurrence after intralesional curettage for primary bone tumors in our study. Tourniquet usage and controlling blood pressure might be beneficial for reducing local recurrence in patients scheduled to receive intralesional curettage for primary bone tumor treatment. LEVEL OF EVIDENCE: Level IV, hypothesis-generating study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05157-4. BioMed Central 2022-03-03 /pmc/articles/PMC8892695/ /pubmed/35241034 http://dx.doi.org/10.1186/s12891-022-05157-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhou, Lenian Lin, Shanyi Zhu, Hongyi Dong, Yang Yang, Qingcheng Yuan, Ting The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study |
title | The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study |
title_full | The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study |
title_fullStr | The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study |
title_full_unstemmed | The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study |
title_short | The blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study |
title_sort | blood pressure and use of tourniquet are related to local recurrence after intralesional curettage of primary benign bone tumors: a retrospective and hypothesis-generating study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892695/ https://www.ncbi.nlm.nih.gov/pubmed/35241034 http://dx.doi.org/10.1186/s12891-022-05157-4 |
work_keys_str_mv | AT zhoulenian thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT linshanyi thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT zhuhongyi thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT dongyang thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT yangqingcheng thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT yuanting thebloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT zhoulenian bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT linshanyi bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT zhuhongyi bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT dongyang bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT yangqingcheng bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy AT yuanting bloodpressureanduseoftourniquetarerelatedtolocalrecurrenceafterintralesionalcurettageofprimarybenignbonetumorsaretrospectiveandhypothesisgeneratingstudy |